PTC THERAPEUTICS, INC. — Director's Dealing 2018

Jun 4, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2018-06-01

Reporting Person: Souza Marcio (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-01	Common Stock	S	5161	$34.65	Disposed	63071	Direct

Footnotes

F1: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 15,000 shares of restricted stock from a May 31, 2017 grant of 30,000 shares.

F2: Includes 1,112 shares acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2017 and 663 shares acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2017. Includes 30,000 shares of a restricted stock award awarded to the Reporting Person on May 31, 2017 and reported on the Form 4 filed by the Reporting Person on June 2, 2017, which shares were inadvertently not previously included in Column 5 of Table 1 on such Form 4.